Showing results (771-780 of 866) with videos related to

Sort By:
Pageof 87
Scientific Reports|July 29, 2021
Practical geospatial and sociodemographic predictors of human mobilityCorrine W Ruktanonchai, Shengjie Lai, Chigozie E Utazi, et al.
The British Journal of Surgery|July 12, 2018
Best-practice care pathway for improving management of mastitis and breast abscessN Patani, F MacAskill, S Eshelby, et al.
Journal of Rare Diseases (Berlin, Germany)|August 21, 2024
Widespread service fragmentation for patients and families with tuberous sclerosis complex (TSC) in the Republic of IrelandM Vasseghi, C Behan, A Connolly, et al.
Investigational New Drugs|June 27, 2013
Patupilone in patients with pretreated metastatic/locally recurrent colorectal cancer: results of the Phase II CINATRA trialS Y Moorcraft, I Chau, C Peckitt, et al.
Leukemia|April 30, 2004
The histone deacetylase inhibitor MS-275 induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia cellsD M Lucas, M E Davis, M R Parthun, et al.
The British Journal of Surgery|July 27, 2018
Lymph node regression and survival following neoadjuvant chemotherapy in oesophageal adenocarcinomaA R Davies, D Myoteri, J Zylstra, et al.
Cancer|May 15, 1996
Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for esophagogastric adenocarcinoma: response, toxicity, quality of life, and survivalA Bamias, M E Hill, D Cunningham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 28, 2017
A randomized, open-label study of the efficacy and safety of AZD4547 monotherapy versus paclitaxel for the treatment of advanced gastric adenocarcinoma with FGFR2 polysomy or gene amplificationE Van Cutsem, Y-J Bang, W Mansoor, et al.
Nanoscale Horizons|September 25, 2024
Towards tunable exciton delocalization in DNA Holliday junction-templated indodicarbocyanine 5 (Cy5) dye derivative heterodimersGissela Pascual, Sebastián A Díaz, Simon K Roy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 3, 2011
A multicentre study of capecitabine, oxaliplatin plus bevacizumab as perioperative treatment of patients with poor-risk colorectal liver-only metastases not selected for upfront resectionR Wong, D Cunningham, Y Barbachano, et al.
Pageof 87